These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 12443664)
1. Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres. Gutierro I; Hernández RM; Igartua M; Gascón AR; Pedraz JL Vaccine; 2002 Nov; 21(1-2):67-77. PubMed ID: 12443664 [TBL] [Abstract][Full Text] [Related]
2. Influence of dose and immunization route on the serum Ig G antibody response to BSA loaded PLGA microspheres. Gutierro I; Hernández RM; Igartua M; Gascón AR; Pedraz JL Vaccine; 2002 May; 20(17-18):2181-90. PubMed ID: 12009271 [TBL] [Abstract][Full Text] [Related]
3. Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres. Igartua M; Hernández RM; Esquisabel A; Gascón AR; Calvo MB; Pedraz JL J Control Release; 1998 Dec; 56(1-3):63-73. PubMed ID: 9801430 [TBL] [Abstract][Full Text] [Related]
4. Immune response after oral administration of the encapsulated malaria synthetic peptide SPf66. Carcaboso AM; Hernández RM; Igartua M; Gascón AR; Rosas JE; Patarroyo ME; Pedraz JL Int J Pharm; 2003 Jul; 260(2):273-82. PubMed ID: 12842346 [TBL] [Abstract][Full Text] [Related]
5. Development of a poly (lactic-co-glycolic acid) particle vaccine to protect against house dust mite induced allergy. Joshi VB; Adamcakova-Dodd A; Jing X; Wongrakpanich A; Gibson-Corley KN; Thorne PS; Salem AK AAPS J; 2014 Sep; 16(5):975-85. PubMed ID: 24981892 [TBL] [Abstract][Full Text] [Related]
6. Immune responses to orally administered PLGA microparticles: influence of oil vehicles and surfactive agents. Gutierro I; Hernández RM; Igartua M; Gascón AR; Pedraz JL J Microencapsul; 2003; 20(4):525-36. PubMed ID: 12851052 [TBL] [Abstract][Full Text] [Related]
7. Prolonged immune response evoked by a single subcutaneous injection of microcapsules having a monophasic antigen release. Sah H; Chien YW J Pharm Pharmacol; 1996 Jan; 48(1):32-6. PubMed ID: 8722491 [TBL] [Abstract][Full Text] [Related]
8. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems. Mohanan D; Slütter B; Henriksen-Lacey M; Jiskoot W; Bouwstra JA; Perrie Y; Kündig TM; Gander B; Johansen P J Control Release; 2010 Nov; 147(3):342-9. PubMed ID: 20727926 [TBL] [Abstract][Full Text] [Related]
9. Allergen-loaded biodegradable poly(D,L-lactic-co-glycolic) acid nanoparticles down-regulate an ongoing Th2 response in the BALB/c mouse model. Schöll I; Weissenböck A; Förster-Waldl E; Untersmayr E; Walter F; Willheim M; Boltz-Nitulescu G; Scheiner O; Gabor F; Jensen-Jarolim E Clin Exp Allergy; 2004 Feb; 34(2):315-21. PubMed ID: 14987314 [TBL] [Abstract][Full Text] [Related]
10. Encapsulation of Aβ(1-15) in PLGA microparticles enhances serum antibody response in mice immunized by subcutaneous and intranasal routes. Puras G; Salvador A; Igartua M; Hernández RM; Pedraz JL Eur J Pharm Sci; 2011 Oct; 44(3):200-6. PubMed ID: 21820509 [TBL] [Abstract][Full Text] [Related]
11. Enhancing immunogenicity and reducing dose of microparticulated synthetic vaccines: single intradermal administration. Carcaboso AM; Hernández RM; Igartua M; Rosas JE; Patarroyo ME; Pedraz JL Pharm Res; 2004 Jan; 21(1):121-6. PubMed ID: 14984266 [TBL] [Abstract][Full Text] [Related]
12. Enhanced mucosal and systemic immune responses obtained by porous silica nanoparticles used as an oral vaccine adjuvant: effect of silica architecture on immunological properties. Wang T; Jiang H; Zhao Q; Wang S; Zou M; Cheng G Int J Pharm; 2012 Oct; 436(1-2):351-8. PubMed ID: 22721849 [TBL] [Abstract][Full Text] [Related]
13. Improved immunogenicity of biodegradable polymer particles entrapped rotavirus vaccine. Nayak B; Ray AR; Panda AK; Ray P J Biomater Appl; 2011 Jan; 25(5):469-96. PubMed ID: 20207774 [TBL] [Abstract][Full Text] [Related]
14. Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles. Carcaboso AM; Hernández RM; Igartua M; Rosas JE; Patarroyo ME; Pedraz JL Vaccine; 2004 Mar; 22(11-12):1423-32. PubMed ID: 15063565 [TBL] [Abstract][Full Text] [Related]
15. Induction of secretory immunity with bioadhesive poly (D,L-lactide-co-glycolide) microparticles containing Streptococcus sobrinus glucosyltransferase. Smith DJ; Trantolo DJ; King WF; Gusek EJ; Fackler PH; Gresser JD; De Souza VL; Wise DL Oral Microbiol Immunol; 2000 Apr; 15(2):124-30. PubMed ID: 11155176 [TBL] [Abstract][Full Text] [Related]
17. Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental autoclaved Leishmania major (ALM) and Quillaja saponins. Tafaghodi M; Eskandari M; Kharazizadeh M; Khamesipour A; Jaafari MR Trop Biomed; 2010 Dec; 27(3):639-50. PubMed ID: 21399606 [TBL] [Abstract][Full Text] [Related]
19. Intranasal immunization against influenza virus using polymeric particles. Lemoine D; Deschuyteneer M; Hogge F; Préat V J Biomater Sci Polym Ed; 1999; 10(8):805-25. PubMed ID: 10487316 [TBL] [Abstract][Full Text] [Related]
20. The effect of lauryl capping group on protein release and degradation of poly(D,L-lactic-co-glycolic acid) particles. Samadi N; Abbadessa A; Di Stefano A; van Nostrum CF; Vermonden T; Rahimian S; Teunissen EA; van Steenbergen MJ; Amidi M; Hennink WE J Control Release; 2013 Dec; 172(2):436-43. PubMed ID: 23751568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]